HAE logo

Haemonetics (HAE) Cash from financing

annual CFF:

$108.82M+$70.66M(+185.18%)
March 29, 2025

Summary

  • As of today (June 11, 2025), HAE annual cash flow from financing activities is $108.82 million, with the most recent change of +$70.66 million (+185.18%) on March 29, 2025.
  • During the last 3 years, HAE annual CFF has risen by +$124.57 million (+790.95%).
  • HAE annual CFF is now -76.44% below its all-time high of $461.85 million, reached on March 30, 2013.

Performance

HAE Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHAEcash flow metrics

quarterly CFF:

-$151.45M-$152.83M(-11074.64%)
March 1, 2025

Summary

  • As of today (June 11, 2025), HAE quarterly cash flow from financing activities is -$151.45 million, with the most recent change of -$152.83 million (-11074.64%) on March 1, 2025.
  • Over the past year, HAE quarterly CFF has dropped by -$87.95 million (-138.50%).
  • HAE quarterly CFF is now -131.65% below its all-time high of $478.58 million, reached on September 29, 2012.

Performance

HAE quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHAEcash flow metrics

TTM CFF:

$108.82M-$87.95M(-44.70%)
March 1, 2025

Summary

  • As of today (June 11, 2025), HAE TTM cash flow from financing activities is $108.82 million, with the most recent change of -$87.95 million (-44.70%) on March 1, 2025.
  • Over the past year, HAE TTM CFF has increased by +$70.66 million (+185.18%).
  • HAE TTM CFF is now -78.50% below its all-time high of $506.10 million, reached on September 29, 2012.

Performance

HAE TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHAEcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HAE Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+185.2%-138.5%+185.2%
3 y3 years+791.0%-1627.9%+791.0%
5 y5 years+182.9%-1431.8%+182.9%

HAE Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+208.4%-145.4%at low-70.8%+201.2%
5 y5-year-70.4%+182.9%-135.0%at low-74.4%+182.9%
alltimeall time-76.4%+182.9%-131.7%at low-78.5%+163.9%

HAE Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
$108.82M(+185.2%)
-
-
Mar 2025
-
-$151.45M(<-9900.0%)
$108.82M(-44.7%)
Dec 2024
-
$1.38M(-101.8%)
$196.77M(-35.4%)
Sep 2024
-
-$74.80M(-122.4%)
$304.81M(-18.2%)
Jun 2024
-
$333.69M(-625.5%)
$372.45M(+876.1%)
Mar 2024
$38.16M(-138.0%)
-
-
Mar 2024
-
-$63.50M(-158.0%)
$38.16M(-61.9%)
Dec 2023
-
$109.43M(-1625.8%)
$100.06M(-269.4%)
Sep 2023
-
-$7.17M(+1099.3%)
-$59.05M(-23.9%)
Jun 2023
-
-$598.00K(-62.7%)
-$77.57M(-22.7%)
Mar 2023
-$100.36M(+537.3%)
-$1.60M(-96.8%)
-$100.36M(-6.7%)
Dec 2022
-
-$49.68M(+93.4%)
-$107.53M(+79.6%)
Sep 2022
-
-$25.69M(+9.8%)
-$59.88M(+59.6%)
Jun 2022
-
-$23.39M(+166.9%)
-$37.51M(+138.2%)
Mar 2022
-$15.75M(-104.3%)
-$8.77M(+330.7%)
-$15.75M(-103.7%)
Dec 2021
-
-$2.04M(-38.6%)
$425.77M(+53.2%)
Sep 2021
-
-$3.31M(+102.9%)
$277.87M(+28.1%)
Jun 2021
-
-$1.63M(-100.4%)
$216.87M(-41.0%)
Mar 2021
$367.45M(-380.1%)
$432.76M(-388.6%)
$367.45M(-781.3%)
Dec 2020
-
-$149.94M(+133.1%)
-$53.94M(-208.2%)
Sep 2020
-
-$64.32M(-143.2%)
$49.85M(+2915.8%)
Jun 2020
-
$148.95M(+1209.8%)
$1.65M(-101.3%)
Mar 2020
-$131.21M(+159.2%)
$11.37M(-124.6%)
-$131.21M(-3.2%)
Dec 2019
-
-$46.15M(-59.0%)
-$135.59M(-18.1%)
Sep 2019
-
-$112.52M(-799.3%)
-$165.64M(+211.3%)
Jun 2019
-
$16.09M(+130.0%)
-$53.20M(+5.1%)
Mar 2019
-$50.63M(-58.0%)
$7.00M(-109.2%)
-$50.63M(-70.3%)
Dec 2018
-
-$76.21M(>+9900.0%)
-$170.28M(+98.5%)
Sep 2018
-
-$79.00K(-100.4%)
-$85.76M(-12.9%)
Jun 2018
-
$18.66M(-116.6%)
-$98.43M(-18.4%)
Mar 2018
-$120.64M(+99.7%)
-$112.65M(-1456.3%)
-$120.64M(+554.3%)
Dec 2017
-
$8.31M(-165.2%)
-$18.44M(-74.4%)
Sep 2017
-
-$12.75M(+259.2%)
-$72.13M(+22.3%)
Jun 2017
-
-$3.55M(-66.0%)
-$58.98M(-2.4%)
Mar 2017
-$60.41M(-3.5%)
-$10.45M(-77.0%)
-$60.41M(-7.9%)
Dec 2016
-
-$45.39M(<-9900.0%)
-$65.62M(+182.6%)
Sep 2016
-
$411.00K(-108.2%)
-$23.22M(-38.6%)
Jun 2016
-
-$4.99M(-68.1%)
-$37.84M(-39.6%)
Mar 2016
-$62.62M(+88.9%)
-$15.65M(+423.5%)
-$62.62M(+40.9%)
Dec 2015
-
-$2.99M(-79.0%)
-$44.45M(+6.6%)
Sep 2015
-
-$14.21M(-52.3%)
-$41.69M(+22.2%)
Jun 2015
-
-$29.77M(-1282.4%)
-$34.12M(+2.9%)
Mar 2015
-$33.16M(+60.2%)
$2.52M(-1234.2%)
-$33.16M(-20.5%)
Dec 2014
-
-$222.00K(-96.7%)
-$41.71M(-20.2%)
Sep 2014
-
-$6.64M(-76.9%)
-$52.29M(-11.4%)
Jun 2014
-
-$28.81M(+377.7%)
-$59.01M(+185.1%)
Mar 2014
-$20.70M(-104.5%)
-$6.03M(-44.2%)
-$20.70M(-52.8%)
Dec 2013
-
-$10.80M(-19.2%)
-$43.85M(+19.1%)
Sep 2013
-
-$13.37M(-240.7%)
-$36.83M(-108.1%)
Jun 2013
-
$9.50M(-132.6%)
$455.13M(-1.5%)
Mar 2013
$461.85M(-1615.8%)
-$29.18M(+673.3%)
$461.85M(-6.9%)
Dec 2012
-
-$3.77M(-100.8%)
$496.28M(-1.9%)
Sep 2012
-
$478.58M(+2849.3%)
$506.10M(-2804.9%)
Jun 2012
-
$16.23M(+209.4%)
-$18.71M(-38.6%)
Mar 2012
-$30.47M(+68.5%)
$5.24M(-13.2%)
-$30.47M(-3.7%)
Dec 2011
-
$6.04M(-113.1%)
-$31.63M(+152.3%)
Sep 2011
-
-$46.22M(-1134.7%)
-$12.54M(-130.3%)
Jun 2011
-
$4.47M(+9.3%)
$41.32M(-328.5%)
Mar 2011
-$18.08M(+29.4%)
$4.09M(-83.7%)
-$18.08M(+4.3%)
Dec 2010
-
$25.13M(+229.1%)
-$17.34M(-76.3%)
Sep 2010
-
$7.64M(-113.9%)
-$73.18M(-16.6%)
Jun 2010
-
-$54.94M(-1236.7%)
-$87.75M(+528.1%)
Mar 2010
-$13.97M(-54.5%)
$4.83M(-115.7%)
-$13.97M(-10.8%)
Dec 2009
-
-$30.71M(+342.7%)
-$15.66M(-204.4%)
Sep 2009
-
-$6.94M(-136.8%)
$14.99M(+483.0%)
Jun 2009
-
$18.84M(+499.6%)
$2.57M(-108.4%)
Mar 2009
-$30.74M
$3.14M(-5814.5%)
-$30.74M(-8.8%)
Dec 2008
-
-$55.00K(-99.7%)
-$33.69M(-12.4%)
Sep 2008
-
-$19.36M(+33.8%)
-$38.47M(-44.4%)
DateAnnualQuarterlyTTM
Jun 2008
-
-$14.46M(-7673.3%)
-$69.22M(-5.5%)
Mar 2008
-$73.23M(+106.0%)
$191.00K(-104.0%)
-$73.23M(+0.8%)
Dec 2007
-
-$4.83M(-90.4%)
-$72.64M(-27.3%)
Sep 2007
-
-$50.11M(+171.2%)
-$99.98M(+83.4%)
Jun 2007
-
-$18.48M(-2483.9%)
-$54.51M(+53.3%)
Mar 2007
-$35.55M(-394.0%)
$775.00K(-102.4%)
-$35.55M(+16.1%)
Dec 2006
-
-$32.16M(+593.2%)
-$30.61M(+1469.1%)
Sep 2006
-
-$4.64M(-1074.8%)
-$1.95M(-125.5%)
Jun 2006
-
$476.00K(-91.7%)
$7.64M(-36.8%)
Mar 2006
$12.09M(-16.8%)
$5.72M(-263.2%)
$12.09M(+5.3%)
Dec 2005
-
-$3.50M(-170.7%)
$11.48M(-43.8%)
Sep 2005
-
$4.95M(+0.5%)
$20.42M(+17.1%)
Jun 2005
-
$4.93M(-3.5%)
$17.44M(+20.0%)
Mar 2005
$14.53M(+1923.8%)
$5.11M(-6.0%)
$14.53M(+284.3%)
Dec 2004
-
$5.43M(+175.6%)
$3.78M(-27.2%)
Sep 2004
-
$1.97M(-2.5%)
$5.19M(+67.8%)
Jun 2004
-
$2.02M(-135.8%)
$3.09M(+330.9%)
Mar 2004
$718.00K(-101.5%)
-$5.64M(-182.5%)
$718.00K(-117.7%)
Dec 2003
-
$6.84M(-5489.0%)
-$4.05M(-75.1%)
Sep 2003
-
-$127.00K(-64.2%)
-$16.28M(-34.0%)
Jun 2003
-
-$355.00K(-96.6%)
-$24.65M(-49.7%)
Mar 2003
-$49.00M(+424.9%)
-$10.41M(+93.4%)
-$49.00M(-30.6%)
Dec 2002
-
-$5.38M(-36.7%)
-$70.58M(+9.8%)
Sep 2002
-
-$8.50M(-65.6%)
-$64.28M(+39.9%)
Jun 2002
-
-$24.70M(-22.8%)
-$45.94M(+392.1%)
Mar 2002
-$9.34M(-400.4%)
-$31.99M(-3604.1%)
-$9.34M(-131.3%)
Dec 2001
-
$913.00K(-90.7%)
$29.82M(-29.5%)
Sep 2001
-
$9.84M(-17.3%)
$42.30M(+57.2%)
Jun 2001
-
$11.90M(+66.1%)
$26.90M(+765.4%)
Mar 2001
$3.11M(-117.5%)
$7.16M(-46.5%)
$3.11M(-127.2%)
Dec 2000
-
$13.39M(-341.0%)
-$11.45M(-34.7%)
Sep 2000
-
-$5.56M(-53.3%)
-$17.53M(-23.0%)
Jun 2000
-
-$11.89M(+60.9%)
-$22.78M(+28.0%)
Mar 2000
-$17.79M(+223.1%)
-$7.39M(-201.2%)
-$17.79M(+11.8%)
Dec 1999
-
$7.30M(-167.6%)
-$15.90M(-12.2%)
Sep 1999
-
-$10.80M(+56.5%)
-$18.11M(+241.3%)
Jun 1999
-
-$6.90M(+25.3%)
-$5.30M(-3.6%)
Mar 1999
-$5.50M(-113.7%)
-$5.50M(-207.9%)
-$5.50M(-788.1%)
Dec 1998
-
$5.10M(+155.0%)
$800.00K(-114.0%)
Sep 1998
-
$2.00M(-128.2%)
-$5.70M(-144.2%)
Jun 1998
-
-$7.10M(-987.5%)
$12.90M(-67.8%)
Mar 1998
$40.10M(+1332.1%)
$800.00K(-157.1%)
$40.10M(+9.0%)
Dec 1997
-
-$1.40M(-106.8%)
$36.80M(+1.4%)
Sep 1997
-
$20.60M(+2.5%)
$36.30M(+87.1%)
Jun 1997
-
$20.10M(-904.0%)
$19.40M(+592.9%)
Mar 1997
$2.80M(-114.7%)
-$2.50M(+31.6%)
$2.80M(-3.4%)
Dec 1996
-
-$1.90M(-151.4%)
$2.90M(-149.2%)
Sep 1996
-
$3.70M(+5.7%)
-$5.90M(-51.6%)
Jun 1996
-
$3.50M(-245.8%)
-$12.20M(-35.8%)
Mar 1996
-$19.00M(-963.6%)
-$2.40M(-77.6%)
-$19.00M(-1.6%)
Dec 1995
-
-$10.70M(+311.5%)
-$19.30M(+221.7%)
Sep 1995
-
-$2.60M(-21.2%)
-$6.00M(-700.0%)
Jun 1995
-
-$3.30M(+22.2%)
$1.00M(-54.5%)
Mar 1995
$2.20M(+22.2%)
-$2.70M(-203.8%)
$2.20M(-66.2%)
Dec 1994
-
$2.60M(-40.9%)
$6.50M(+1200.0%)
Sep 1994
-
$4.40M(-309.5%)
$500.00K(>+9900.0%)
Jun 1994
-
-$2.10M(-231.3%)
$0.00(-100.0%)
Mar 1994
$1.80M(-116.7%)
$1.60M(-147.1%)
$1.80M(-700.0%)
Dec 1993
-
-$3.40M(-187.2%)
-$300.00K(<-9900.0%)
Sep 1993
-
$3.90M(-1400.0%)
$0.00(-100.0%)
Jun 1993
-
-$300.00K(-40.0%)
-$10.30M(-4.6%)
Mar 1993
-$10.80M(-1450.0%)
-$500.00K(-83.9%)
-$10.80M(-18.8%)
Dec 1992
-
-$3.10M(-51.6%)
-$13.30M(+160.8%)
Sep 1992
-
-$6.40M(+700.0%)
-$5.10M(-304.0%)
Jun 1992
-
-$800.00K(-73.3%)
$2.50M(+212.5%)
Mar 1992
$800.00K
-$3.00M(-158.8%)
$800.00K(-78.9%)
Dec 1991
-
$5.10M(+325.0%)
$3.80M(-392.3%)
Sep 1991
-
$1.20M(-148.0%)
-$1.30M(-48.0%)
Jun 1991
-
-$2.50M
-$2.50M

FAQ

  • What is Haemonetics annual cash flow from financing activities?
  • What is the all time high annual CFF for Haemonetics?
  • What is Haemonetics annual CFF year-on-year change?
  • What is Haemonetics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Haemonetics?
  • What is Haemonetics quarterly CFF year-on-year change?
  • What is Haemonetics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Haemonetics?
  • What is Haemonetics TTM CFF year-on-year change?

What is Haemonetics annual cash flow from financing activities?

The current annual CFF of HAE is $108.82M

What is the all time high annual CFF for Haemonetics?

Haemonetics all-time high annual cash flow from financing activities is $461.85M

What is Haemonetics annual CFF year-on-year change?

Over the past year, HAE annual cash flow from financing activities has changed by +$70.66M (+185.18%)

What is Haemonetics quarterly cash flow from financing activities?

The current quarterly CFF of HAE is -$151.45M

What is the all time high quarterly CFF for Haemonetics?

Haemonetics all-time high quarterly cash flow from financing activities is $478.58M

What is Haemonetics quarterly CFF year-on-year change?

Over the past year, HAE quarterly cash flow from financing activities has changed by -$87.95M (-138.50%)

What is Haemonetics TTM cash flow from financing activities?

The current TTM CFF of HAE is $108.82M

What is the all time high TTM CFF for Haemonetics?

Haemonetics all-time high TTM cash flow from financing activities is $506.10M

What is Haemonetics TTM CFF year-on-year change?

Over the past year, HAE TTM cash flow from financing activities has changed by +$70.66M (+185.18%)
On this page